• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problems Improper or Incorrect Procedure or Method (2017); No Apparent Adverse Event (3189)
Patient Problem Red Eye(s) (2038)
Event Date 12/21/2023
Event Type  malfunction  
Event Description
The consumer reported an accidental reagent exposure to the eyes with a binaxnow covid-19 antigen self-test on (b)(6).2023.Per the consumer, she accidently put reagent into her eyes as she was opening the bottle of the reagent.The consumer had mistakenly used the reagent solution as her eye drops.Consumer stated her eyes became red after flushing with water.Consumer also stated she was not having any irritation and was fine after the exposure and did not require any further medical intervention.There was no reported patient impact.No additional information was provided.
 
Manufacturer Narrative
Fda udi ¿ (b)(4).The remainder of the investigation remains in progress.A supplemental report will be provided after completion.H3 other text : single use; device discarded.
 
Manufacturer Narrative
Fda udi ¿ (b)(4).A product deficiency was not reported or found.Technical service provided the safety data sheet.A supplemental report will be provided if any additional information is obtained.The reported health status is anticipated in nature and severity for binaxnow covid-19 ag card risk documentation.H3 other text : single use; device discarded.
 
Event Description
The consumer reported an accidental reagent exposure to the eyes with a binaxnow covid-19 antigen self-test on (b)(6) 2023.The consumer mistakenly used the reagent solution as her eye drops.Consumer stated her eyes became red after flushing with water.Consumer also stated she was not having any irritation and was fine after the exposure and did not require any further medical intervention.There was no reported patient impact.No additional information was provided.
 
Event Description
The consumer reported an accidental reagent exposure to the eyes with a binaxnow covid-19 antigen self-test on (b)(6) 2023.The consumer mistakenly used the reagent solution as her eye drops.Consumer stated her eyes became red after flushing with water.Consumer also stated she was not having any irritation and was fine after the exposure and did not require any further medical intervention.There was no reported patient impact.No additional information was provided.
 
Manufacturer Narrative
Fda udi ¿ (b)(4) the remainder of the investigation remains in progress.A supplemental report will be provided after completion.B5 h-6: medical device problem code h3 other text : single use; device discarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key18463032
MDR Text Key332381521
Report Number1221359-2024-00034
Device Sequence Number1
Product Code QKP
UDI-Device Identifier00811877011408
UDI-Public00811877011408
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 01/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/08/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date11/10/2023
Device Catalogue Number195-160
Device Lot Number186913
Was Device Available for Evaluation? No
Date Manufacturer Received01/10/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age60 YR
Patient SexFemale
Patient Weight61 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-